Literature DB >> 3079959

Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments.

R J Levy, F J Schoen, F S Sherman, J Nichols, M A Hawley, S A Lund.   

Abstract

Although collagen-containing implants are widely used in various surgical applications, there has been relatively little attention paid to the possibility that this type of biomaterial may undergo pathologic calcification which could compromise its function. The present study reports for the first time the calcification of a series of implants of purified collagen sponges prepared with graded degrees of aldehyde-induced cross-linkages (assessed by shrinkage-temperature, wetting time, and collagenase digestibility). Type I collagen sponges were pretreated with either glutaraldehyde (0.1% to 2.0% aqueous solution, for 5-180 minutes) or formaldehyde (as vapors for 15 minutes to 15 hours), and implanted subcutaneously for 21 days in weanling rats. Although specimens not pretreated with either aldehyde reagent and the formaldehyde sponges pretreated for 15 minutes were resorbed without evidence of calcification, all other aldehyde-pretreated implants mineralized. The degree of calcification did not correlate with extent of cross-linking. Formaldehyde-pretreated implants calcified more extensively (Ca2+ = 87.8 +/- 2.8 micrograms/mg, mean +/- standard error of the mean; n = 58) than did glutaraldehyde-pretreated implants (Ca2+ = 40.9 +/- 1.4 micrograms/mg; n = 52). It is concluded that both glutaraldehyde- and formaldehyde-pretreated Type I collagen sponges calcify after subdermal implantation in young rats. Although aldehyde pretreatment of Type I collagen sponge implants is a prerequisite for their eventual mineralization, the threshold level of aldehyde-induced cross-linking required to potentiate their maximal pathologic calcification is low.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079959      PMCID: PMC1888125     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  An experimental and clinical evaluation of surgical suture materials.

Authors:  E T MADSEN
Journal:  Surg Gynecol Obstet       Date:  1953-07

2.  Mechanism of crosslinking of proteins by glutaraldehyde III. Reaction with collagen in tissues.

Authors:  D T Cheung; N Perelman; E C Ko; M E Nimni
Journal:  Connect Tissue Res       Date:  1985       Impact factor: 3.417

3.  Biological factors affecting long-term results of valvular heterografts.

Authors:  A Carpentier; G Lemaigre; L Robert; S Carpentier; C Dubost
Journal:  J Thorac Cardiovasc Surg       Date:  1969-10       Impact factor: 5.209

4.  Bioprosthetic heart valve failure: pathology and pathogenesis.

Authors:  F J Schoen; R J Levy
Journal:  Cardiol Clin       Date:  1984-11       Impact factor: 2.213

5.  Surface morphology and correlated phagocytic capacity of pulmonary macrophages lavaged from the lungs of rats.

Authors:  D B Warheit; L H Hill; A R Brody
Journal:  Exp Lung Res       Date:  1984       Impact factor: 2.459

6.  Modification of polyetherurethane for biomedical application by radiation induced grafting. II. Water sorption, surface properties, and protein adsorption of grafted films.

Authors:  B Jansen; G Ellinghorst
Journal:  J Biomed Mater Res       Date:  1984 Jul-Aug

7.  Modification by the Hancock T6 process of calcification of bioprosthetic cardiac valves implanted in sheep.

Authors:  E Arbustini; M Jones; R D Moses; E E Eidbo; R J Carroll; V J Ferrans
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

8.  Onset and progression of experimental bioprosthetic heart valve calcification.

Authors:  F J Schoen; R J Levy; A C Nelson; W F Bernhard; A Nashef; M Hawley
Journal:  Lab Invest       Date:  1985-05       Impact factor: 5.662

9.  Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate.

Authors:  R J Levy; J Wolfrum; F J Schoen; M A Hawley; S A Lund; R Langer
Journal:  Science       Date:  1985-04-12       Impact factor: 47.728

10.  Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats.

Authors:  R J Levy; M A Hawley; F J Schoen; S A Lund; P Y Liu
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

View more
  23 in total

1.  Activity of MMP-9 after repair of abdominal wall defects with acellular and crosslinked bovine pericardium in rabbit.

Authors:  Himani Singh; Naveen Kumar; A K Sharma; Meena Kataria; Ashok Munjal; Amit Kumar; Rukmani Dewangan; Vineet Kumar; J Devarathnam; Sachin Kumar
Journal:  Int Wound J       Date:  2012-06-22       Impact factor: 3.315

2.  Alkaline phosphatase induces the mineralization of sheets of collagen implanted subcutaneously in the rat.

Authors:  W Beertsen; T van den Bos
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

3.  Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy.

Authors:  B Chevallay; D Herbage
Journal:  Med Biol Eng Comput       Date:  2000-03       Impact factor: 2.602

4.  Crosslinking of cell-derived 3D scaffolds up-regulates the stretching and unfolding of new extracellular matrix assembled by reseeded cells.

Authors:  Kristopher E Kubow; Enrico Klotzsch; Michael L Smith; Delphine Gourdon; William C Little; Viola Vogel
Journal:  Integr Biol (Camb)       Date:  2009-10-27       Impact factor: 2.192

5.  A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response.

Authors:  Yoshinori Onuki; Upkar Bhardwaj; Fotios Papadimitrakopoulos; Diane J Burgess
Journal:  J Diabetes Sci Technol       Date:  2008-11

6.  To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices.

Authors:  Luis M Delgado; Yves Bayon; Abhay Pandit; Dimitrios I Zeugolis
Journal:  Tissue Eng Part B Rev       Date:  2015-03-12       Impact factor: 6.389

7.  Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization.

Authors:  F J Schoen; J W Tsao; R J Levy
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

8.  Development of a Cell-Based Gene Therapy Approach to Selectively Turn Off Bone Formation.

Authors:  Pedro Alvarez-Urena; Banghe Zhu; Gabrielle Henslee; Corinne Sonnet; Eleanor Davis; Eva Sevick-Muraca; Alan Davis; Elizabeth Olmsted-Davis
Journal:  J Cell Biochem       Date:  2017-07-31       Impact factor: 4.429

9.  Exogenous hyaluronic acid and chondroitin sulfate crosslinking treatment for increasing the amount and stability of glycosaminoglycans in bioprosthetic heart valves.

Authors:  Yang Lei; Qinggong Ning; Yuyang Tang; Yunbing Wang
Journal:  J Mater Sci Mater Med       Date:  2019-03-06       Impact factor: 3.896

10.  Biochemical differences between dystrophic calcification of cross-linked collagen implants and mineralization during bone induction.

Authors:  M E Nimni; S Bernick; D T Cheung; D C Ertl; S K Nishimoto; W J Paule; C Salka; B S Strates
Journal:  Calcif Tissue Int       Date:  1988-05       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.